🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I/II, open-label, single arm, two-stage trial to evaluate the singl...
Status
Unknown
Location
Tygerberg Hospital
Start Date
2022-09-12
Trial ID
NCT05590325
Treatments Being Tested
The purpose of this study is to evaluate steady-state pharmacokinetics of D...
Status
Unknown
Location
Division of Infectious disease, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University
Start Date
2021-08-03
Trial ID
NCT05006170
Treatments Being Tested
Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. Th...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program (Site ID: 4601)
Start Date
2011-04-20
Trial ID
NCT01302847
Dolutegravir (DTG) is an HIV-1 integrase inhibitor approved in the United S...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07
Trial ID
NCT02185300
Treatments Being Tested